Treatment Conditioning Variables in Elderly Patients With Acute Myeloid Leukemia

Article Sidebar

PDF (Spanish)
Published: 2016-06-30
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v36i2.675

Main Article Content

Alberto Giménez Conca
Central de Emergencias de Adultos, Servicio de Clínica Médica. Hospital Italiano de Buenos Aires

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 36 No. 2 (2016): Revista del Hospital Italiano de Buenos Aires

Section

Hospital Italiano in Medline
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Giménez Conca A. Treatment Conditioning Variables in Elderly Patients With Acute Myeloid Leukemia. Rev Hosp Ital B.Aires [Internet]. 2016 Jun. 30 [cited 2026 Jun. 6];36(2):59-60. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/675

References

Dombret H, Raffoux E, Gardin C. New insights in the management of elderly patients with acute myeloid leukemia. Curr Opin Oncol. 2009;21(6):589-93. DOI: https://doi.org/10.1097/CCO.0b013e3283313e10

Malfuson JV, Etienne A, Turlure P, et al. Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia. Haematologica. 2008;93(12):1806-13 DOI: https://doi.org/10.3324/haematol.13309

Rathnasabapathy R, Lancet JE. Management of acute myelogenous leukemia in the elderly. Cancer Control. 2003;10(6):469-77. DOI: https://doi.org/10.1177/107327480301000605

Juliusson G, Antunovic P, Derolf A, et al. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry. Blood. 2009;113(18):4179-87 DOI: https://doi.org/10.1182/blood-2008-07-172007

Büchner T, Berdel WE, Haferlach C, et al. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group. J Clin Oncol. 2009;27(1):61-9. DOI: https://doi.org/10.1200/JCO.2007.15.4245

Gupta V, Chun K, Yi QL, et al. Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy. Cancer. 2005;103(10):2082-90. DOI: https://doi.org/10.1002/cncr.21006

Kantarjian H, O’brien S, Cortes J, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer. 2006;106(5):1090-8. DOI: https://doi.org/10.1002/cncr.21723